Are you interested in attending ADLM 2024 (formerly AACC Annual Scientific Meeting & Clinical Lab Expo), but uncertain how to persuade your employer to fund your registration? Follow these five simple steps to prepare a request for your boss.
Pinpoint the biggest challenges your lab or organization faces, especially the ones that relate directly to your position.
With those challenges in mind, search through the ADLM 2024's 250+ educational sessions to identify the ones that address the issues you’re facing.
Also be sure to look through ADLM 2024's 900+ exhibiting companies and identify the vendors that offer the diagnostic solutions your lab needs.
Use your research in Step 2 to create a succinct proposal for your boss that explains why sending you to ADLM 2024 will benefit your organization and the patients you serve. Include your top challenges, and outline how the sessions and exhibitors you’ve identified will equip you to handle them.
Additional reasons to justify your attendance include:
In case your boss needs or prefers your request in writing, we’ve drafted an approval request template letter. Feel free to use and edit this letter as needed and send it to your supervisor:
Download the Letter
After ADLM 2024, hold a post-conference briefing with relevant lab staff to share what you learned—from best practices to the low-down on new diagnostic instruments—and develop a strategy for putting this knowledge into action.
You’ll positively impact your lab and the patients it serves, which will pave the way to convince your boss to send you back to the ADLM Annual Meeting in 2025.
Check out the scientific sessions at ADLM 2024. Register and start planning your schedule today.
ADLM 2024 offers something for everyone in laboratory medicine, from Plenaries featuring world-renowned scientists to intimate Roundtables.
Join us in Chicago at ADLM 2024. ADLM members save $300+, get complimentary session recordings, access to the popular member lounge, plus more with Chicago All Access registration.
Be the first to get all the latest news.